Skip to main content
Vilcek Foundation
  • About
    • About

      The Vilcek Foundation raises awareness of immigrant contributions in the United States and fosters appreciation of the arts and sciences.

    • Our Mission
    • Our Founders
    • Our Team
    • Press Center
    • Contact
  • Prizes
    • Prizes

      The Vilcek Foundation Prizes celebrate extraordinary achievements in the arts and sciences.

    • About the Prizes
    • Prize Recipients
    • Vilcek Prizes

      Awards immigrants with a legacy of major accomplishments.

    • Vilcek Prizes for Creative Promise

      Recognizes young immigrant professionals for outstanding achievements.

    • Vilcek Prize for Excellence

      Celebrating intellectual and cultural leaders in the United States.

    • Marica Vilcek Prize in Art History

      Honors art historians, curators, and fine arts professionals.

  • Art
  • Grants
    • Grants

      Grants awarded to 501(c)(3) cultural, educational, and philanthropic organizations in the United States.

    • Grants

      Learn more and apply for a grant.

    • Grants History

      Explore a list of past Vilcek Foundation grantees.

  • Events
  • News
Sign Up Search
Home > News > Mutations and Multiplication: Angelika Amon Unravels Cell Division

Mutations and Multiplication: Angelika Amon Unravels Cell Division

News | February 8, 2019
Tags
aneuploidy biology biomedical science cancer research cell function cell growth chromosomes Howard Hughes Medical Institute MIT molecular biology
Share this page
Share this page on X Share this page on Facebook Share this page on LinkedIn

Angelika Amon’s outstanding career as a geneticist could be said to have started during her high school years. In a science class in her native Austria, a teacher showed an old black-and-white movie clip of a plant cell in mitosis, the process by which cells divide. Struck by its beauty, the future Vilcek Prizewinner decided to pursue molecular and cell biology during her undergraduate and postgraduate studies at the University of Vienna.

She was so enamored that, upon learning a new laboratory on cell division was being established, Angelika decided she would see it for herself. She took the tram to the lab’s site, knocked on the door unannounced, and, without ceremony, asked for a student position. “At that time, I was so naïve,” Angelika says.

The laboratory was in Vienna’s renowned Institute of Molecular Pathology, and the principal investigator was the recently arrived English geneticist Kim Nasmyth, among the world’s foremost authorities on the genetics of cell division. “To this day, I’m still convinced Kim only took me into his lab because he wanted to learn German,” Angelika says, only half joking.

Kim’s proficiency in German may well have improved, but it is undeniable what Angelika contributed to his lab’s output, first as a master’s candidate and then as a doctoral student. While at IMP, she used yeast organisms to uncover the logic that ensured orderly progression through the cell cycle, as living cells go through the process of replicating their genetic material, dividing its contents, and splitting into two separate entities.

“We showed how the cell cycle is interconnected,” Angelika says, “and how one cell cycle phase sets up the next one.” In a paper published through Kim’s lab, Angelika demonstrated that in order for cells to exit mitosis, they first had to degrade proteins called cyclin, the initial triggers that induce cell division; she also identified other cues that prompt stages to start and finish, like a tightly run production schedule.

After completing her doctorate, Angelika set sail for the U.S. for a postdoctoral fellowship with geneticist Ruth Lehmann, then at the Whitehead Institute; she admired Ruth’s elegant papers and was excited by the possibility of working with a female role model at a time when there were few in the sciences.

Halfway through her fellowship, Angelika was offered the prestigious Whitehead fellowship for young scientists. It allowed Angelika to strike out on her own, and she continued to display an uncanny insight into the processes of cell division, in time identifying various enzymes, networks, and spacial signals that regulate the process of mitosis.

Having uncovered the incredibly precise mechanisms governing cell division, Angelika then turned her attention to what happens when these signals get crossed. By then, she had been appointed as a faculty member of MIT’s Koch Institute for Integrative Cancer Research, and she was struck by the paradox found in human cancer cells: It was long known that cancer cells are aneuploid—a state that occurs when errors during division cause cells to harbor an incorrect number of chromosomes. In healthy cells, such a state is typically lethal, or it results in diseases such as Down syndrome.

For cancer cells, however, aneuploidy did not hamper their ability to divide and proliferate. In order to understand the impact of aneuploidy, Angelika built yeast models to parse out its effects. What she found was that aneuploidy caused a variety of gene-specific effects, depending on which chromosomes had been corrupted. These effects were manifold, but Angelika found that some aneuploidies could be beneficial for cancer cells, through an intricate interplay with other tumorigenic factors.

Even more breathtaking, however, was the characterization of universal stresses created by aneuploidy. “Cancer cells are all aneuploid, so these stresses that we see in aneuploidy could be an Achilles’ heel,” Angelika says. And indeed, her lab was able to devise chemical compounds that identified and destroyed aneuploid cells while leaving euploid cells intact. Later, her lab found that aneuploid human cells trigger an innate immune response, something that cancer cells had adapted to avoid, opening more possibilities for targeted cancer treatments.

Although these discoveries hold enormous potential, it was a while before the implications of Angelika’s research were taken seriously. For one, the field was resistant to the idea that aneuploidy reduced cellular fitness despite being a driver of cancer; then, there was the fact that she is a woman. “Over the course of my career, I’ve seen firsthand how much harder it is for women to convince the scientific enterprise that what they discovered is important,” Angelika says.

The field, however, has finally started to catch up: Among many other honors, Angelika was named a winner of the 2019 Breakthrough Prize, the recently established science mega-prize, as well as the 2013 Ernst Jung Prize for Medicine. She is a member of the American Academy of Arts and Sciences, the National Academy of Sciences, and the European Molecular Biology Organization, and holds a Howard Hughes Medical Investigatorship.

Remembering how formative it was to have a female role model, Angelika has taken up the mantle herself, earning further distinctions for her efforts: She received the Vanderbilt Prize in Biomedical Science, awarded to women scientists with exemplary records of research as well as mentorship, and the Women in Cancer Research Charlotte Friend Memorial Lectureship, presented to scientists who have furthered the advancement of women in the field.

Angelika is committed to helping her female colleagues, but she is quick to admit that while positive changes are needed, the U.S. has allowed her to accomplish many things that she could not have had she stayed in Austria. “What I love about the U.S. is that what counts is what you accomplish,” she says. “A lot of people pushed for me, but not because they owed my father a favor or were family friends, which is how things are done in Austria. They pushed for me because they thought I was talented.”

Tags
aneuploidy biology biomedical science cancer research cell function cell growth chromosomes Howard Hughes Medical Institute MIT molecular biology
Share this page
Share this page on X Share this page on Facebook Share this page on LinkedIn

Related News

February 3, 2025

Vilcek Foundation Awards $250,000 to Immigrants in Biomedical Science

Meet the recipients of the 2025 Vilcek Foundation Prizes in Biomedical Science: Marianne Bronner, Elham Azizi, Guosong Hong, and Maayan Levy.
Four diagonal splices featuring portraits of Marianne Bronner, Elham Azizi, Guosong Hong, and Maayan Levy, against a red background.
February 3, 2025

Marianne Bronner: Advancing Stem Cell Research and Equity in Science

Discover Vilcek Prize winner Marianne Bronner’s unique path from a Hungarian immigrant to a groundbreaking developmental biologist.
Marianne wearing a white lab coat with her arms crossed.
March 19, 2020

Kivanç Birsoy: “I feel like I contribute—at least—to the understanding of this disease”

Kivanç Birsoy’s research at The Rockefeller University focuses on cancer cell metabolism and its therapeutic applications.
Kivanc Birsoy is the head of Birsoy lab at Rockefeller University

You may also be interested in

Silvi Rouskin

Silvi Rouskin receives the Vilcek Prize for Creative Promise in Biomedical Science for developing methods to unravel the shapes of RNA molecules inside cells and aiding the potential development of RNA-based therapeutics.
Portrait of Silvi Rouskin

Kivanç Birsoy

Kıvanç Birsoy receives the Vilcek Prize for Creative Promise in Biomedical Science for developing cutting-edge tools to unravel the altered metabolism of cancer cells and uncovering molecular targets for treatment.
Portrait of Kivanc Birsoy

Angelika Amon

Angelika Amon (1967-2020) receives the Vilcek Prize in Biomedical Science for groundbreaking research on the molecular signals that regulate cell growth and division, and how errors in these processes contribute to birth defects and cancer.
Portrait of Angelika Amon

Join our mailing list

Sign Up
Vilcek Foundation
21 East 70th Street
New York, New York 10021

Phone: 212.472.2500

Email: info@vilcek.org

  • About
    • Our Mission
    • Our Founders
    • Our Team
    • Press Center
    • Contact
  • Prizes
    • Prize Recipients
    • Vilcek Prizes
    • Vilcek Prizes for Creative Promise
    • Vilcek Prize for Excellence
    • Marica Vilcek Prize in Art History
  • Art
  • Grants
    • Grants History
  • Events
  • News
  • Careers
Connect with us
  • Connect with the Vilcek Foundation on Facebook
  • Connect with the Vilcek Foundation on Instagram
  • Connect with the Vilcek Foundation on X
  • Connect with the Vilcek Foundation on LinkedIn
  • Connect with the Vilcek Foundation on Youtube
  • Connect with the Vilcek Foundation on Vimeo
  • Privacy Policy
  • Accessibility Statement
© 2025   Vilcek Foundation
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok